Covered recipient · General Payments record
JOYCE M MISKOVIC
Physician Assistants & Advanced Practice Nursing Providers Nurse Practitioner Adult Health
General Payments · PY2023–2024
$148,664.89
- Reported across 61 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Consulting Fee | $118,441.81 | 48 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| GlaxoSmithKline, LLC. | $118,441.81 | 48 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (48)
Sorted by paying entity, then date · as published by CMS
Program year 2024 2023
Record-level detail is published for PY2024; earlier years are summarised in
“By program year”.
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| GlaxoSmithKline, LLC. | $2,178.24 | 01/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116305809 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 01/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116312750 | CMS |
| GlaxoSmithKline, LLC. | $2,178.24 | 01/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116519938 | CMS |
| GlaxoSmithKline, LLC. | $2,552.63 | 01/27/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116080527 | CMS |
| GlaxoSmithKline, LLC. | $2,178.24 | 02/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116021127 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 02/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1115924774 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 02/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116645442 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 02/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116284772 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 03/05/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116422933 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 03/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1115860935 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 03/18/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116601171 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 03/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116468986 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 04/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116194188 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 04/06/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116517802 | CMS |
| GlaxoSmithKline, LLC. | $1,633.68 | 04/15/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116426789 | CMS |
| GlaxoSmithKline, LLC. | $2,178.24 | 04/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1115731658 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 04/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1115822858 | CMS |
| GlaxoSmithKline, LLC. | $2,110.17 | 05/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116524066 | CMS |
| GlaxoSmithKline, LLC. | $2,178.24 | 05/12/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116135530 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 05/20/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116721211 | CMS |
| GlaxoSmithKline, LLC. | $2,178.24 | 05/24/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116279711 | CMS |
| GlaxoSmithKline, LLC. | $2,178.24 | 06/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116558297 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 06/10/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116307351 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 06/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116571249 | CMS |
| GlaxoSmithKline, LLC. | $2,178.24 | 07/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1115982805 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 07/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116162179 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 07/22/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116587681 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 07/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116022127 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 08/03/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116681757 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 08/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116394112 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 08/17/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116334541 | CMS |
| GlaxoSmithKline, LLC. | $2,178.24 | 08/26/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116456593 | CMS |
| GlaxoSmithKline, LLC. | $2,178.24 | 09/01/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116383050 | CMS |
| GlaxoSmithKline, LLC. | $2,178.24 | 09/09/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116548113 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 09/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1115982821 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 09/23/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116194645 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 09/30/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116254089 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 10/07/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116706607 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 10/14/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116194638 | CMS |
| GlaxoSmithKline, LLC. | $2,722.80 | 10/21/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116328612 | CMS |
| GlaxoSmithKline, LLC. | $2,518.59 | 10/28/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116613382 | CMS |
| GlaxoSmithKline, LLC. | $2,654.73 | 11/04/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116650761 | CMS |
| GlaxoSmithKline, LLC. | $1,633.68 | 11/11/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116353226 | CMS |
| GlaxoSmithKline, LLC. | $2,178.24 | 11/19/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116568761 | CMS |
| GlaxoSmithKline, LLC. | $2,586.66 | 11/25/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1115990981 | CMS |
| GlaxoSmithKline, LLC. | $1,633.68 | 11/29/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1115922891 | CMS |
| GlaxoSmithKline, LLC. | $2,620.70 | 12/08/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116642594 | CMS |
| GlaxoSmithKline, LLC. | $1,565.61 | 12/16/2024 | Consulting Fee | Undisputed | 01/23/2026 | 1116217629 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2023, 2024
- Source files
- Dataset page · Bulk file · PY2023 , PY2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.